Waters Parkerson & Co’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,040	Closed	-$304K	–	186
2024 Q3	$304K	Buy	+3,040	New	+$304K	0.02%	159